secwatch.observer — SEC 8-K summary
======================================

Issuer:     Avidity Biosciences, Inc. (—)
CIK:        0001599901
Form:       8-K
Filed at:   2025-04-29T23:59:59+00:00
Accession:  0001599901-25-000091
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avidity Biosciences appoints Deloitte as auditor; dismisses BDO effective after Q1 2025 filing
--------------------------------------------------------------------------------

- Deloitte & Touche appointed as independent registered public accounting firm for FY2025, effective after Q1 2025 10-Q filing.
- BDO dismissed on April 25, 2025; its 2023-2024 audit opinions were unqualified with no disagreements.
- 2023 material weakness in ITGC segregation of duties was fully remediated and BDO issued unqualified opinion on 2024 ICFR.
- Company did not consult Deloitte on any accounting or audit matters prior to appointment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1599901/000159990125000091/0001599901-25-000091-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1599901/000159990125000091/rna-20250425.htm
  HTML page:      https://secwatch.observer/filing/0001599901-25-000091

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer